NCT06026319View on ClinicalTrials.gov

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2028

Conditions
Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaFollicular LymphomaMarginal Zone LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)High-grade B-cell LymphomaGrade 3b Follicular LymphomaMantle Cell Lymphoma
Interventions
DRUG

CD79b-19 CAR T cells

Intravenous infusion

DRUG

Cyclophosphamide

Intravenous infusion

DRUG

Fludarabine

Intravenous infusion

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Marcela V. Maus, M.D.,Ph.D.

OTHER